Acelrx Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
You have viewed 7 of the 10 daily limit
Subscribe for $29/month to gain full access
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Acelrx Pharmaceuticals Inc
TickerTLPH
CIK #0001427925
CUSIP00444T209
SectorLife Sciences - Pharmaceutical Preparations
Address575 Chesapeake Drive, Redwood City, CA 94063
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Talphera Inc 2025-09-15 17.0 M Exemption: 506(b) · Remaining: $11,984,998 · Duration: More than one year · Revenue: Decline to Disclose
Acelrx Pharmaceuticals Inc 2023-07-28 10.0 M Exemption: 506(b) · Duration: One year or less · Commission: $625,001 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001427925] 10-K
[0001427925] 10-Q
[0001427925] 3
[0001427925] 4
[0001427925] 5
[0001427925] 8-K
[0001427925] D
[0001427925] SC 13D
[0001427925] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Hirschman Orin Talphera Inc [2025-11-10] 0.0
Rosalind Advisors Inc Talphera Inc [2025-04-11] 0.0
Nantahala Capital Management LLC Talphera Inc [2024-01-23] 11.8
Lind Global Fund II LP Acelrx Pharmaceuticals Inc [2023-08-01] 6.5
Armistice Capital LLC Acelrx Pharmaceuticals Inc [2022-02-15] 0.99
BML Investment Partners LP Acelrx Pharmaceuticals Inc [2020-10-27] 4.5
BML Investment Partners LP Acelrx Pharmaceuticals Inc [2020-10-27] 4.5
BlackRock Inc Acelrx Pharmaceuticals Inc [2020-02-07] 7.1
Industry Ventures Secondary VIII LP Acelrx Pharmaceuticals Inc [2018-05-31] 7.3
Leerink Revelation Healthcare Fund I LP Acelrx Pharmaceuticals Inc [2018-05-31] 7.3
Sophrosyne Capital LLC Acelrx Pharmaceuticals Inc [2013-01-11] 5.1
Perceptive Advisors LLC Acelrx Pharmaceuticals Inc [2012-12-13] 14.25
[2012-06-07] None
FMR LLC Acelrx Pharmaceuticals Inc [2012-02-14] 0.0
Form 3/4/5 Filer 2011 - 2026
Talphera Inc
Broadfoot Jill Marie
Jain Abhinav
Bozilenko Marina
Todisco Joseph
Wan Mark A
Hoffman Stephen J
Adams Adrian
Aslam Shakil
Asadorian Raffi
Dasu Badri N
Angotti Vincent J
Nantahala Capital Management LLC
Harkey Wilmot B
Mack Daniel
Palmer Pamela P
Afable Richard
Rosen Howard B
Edwards Mark G
Hamel Lawrence G
Hoffman C Steven
Three Arch Associates IV LP
Three Arch Partners IV LP
Jaeger Wilfred E
Three Arch Associates III LP
Three Arch Partners III LP
Saia John G
Perceptive Life Sciences Master Fund Ltd
Edelman Joseph
Perceptive Advisors LLC
Wright-Mitchell Jane
Morris Timothy E
Yatra Online Inc
King Richard
Kaneko Yasunori
Skyline Venture Partners Qualified Purchaser Fund IV L P
Skyline Venture Management IV LLC
Freund John Gordon
Welch James H
Chung David
Nohra Guy P
Schreck Thomas A
Three Arch Associates L P
Three Arch Partners L P
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Angotti Vincent J
Common Stock
2026-03-13 Buy 213,310 $0.59 125,853
Nantahala Capital Management LLC +2
Pre-Funded Warrants · derivative
2026-03-13 Grant 4,266,211 $0.59 2,517,064
Angotti Vincent J
Common Stock
2026-02-14 Tax withheld 9,559 $0.79 7,552
Asadorian Raffi
Common Stock
2026-02-14 Tax withheld 2,933 $0.79 2,317
Dasu Badri N
Common Stock
2026-02-14 Tax withheld 2,346 $0.79 1,853
Aslam Shakil
Common Stock
2026-02-12 Buy 35,000 $0.81 28,350
Asadorian Raffi
Commom Stock
2026-02-12 Buy 45,000 $0.81 36,450
Angotti Vincent J
Common Stock
2026-02-12 Buy 105,364 $0.81 85,345
Dasu Badri N
Common Stock
2026-02-12 Buy 35,000 $0.81 28,350
Aslam Shakil
Stock Option (Right to Buy) · derivative
2026-02-12 Grant 205,000 $0.00
Angotti Vincent J
Stock Option (Right to Buy) · derivative
2026-02-12 Grant 594,000 $0.00
Dasu Badri N
Stock Option (Right to Buy) · derivative
2026-02-12 Grant 200,000 $0.00
Asadorian Raffi
Stock Option (Right to Buy) · derivative
2026-02-12 Grant 260,000 $0.00
Asadorian Raffi
Common Stock
2026-02-10 Tax withheld 958 $0.84 805
Dasu Badri N
Common Stock
2026-02-10 Tax withheld 781 $0.84 656
Angotti Vincent J
Common Stock
2026-02-10 Tax withheld 3,179 $0.84 2,670
Broadfoot Jill Marie
Stock Option (Right to Buy) · derivative
2025-10-23 Grant 25,600 $0.00
Jain Abhinav
Stock Option (Right to Buy) · derivative
2025-10-23 Grant 25,600 $0.00
Hoffman Stephen J
Common Stock
2025-10-23 Grant 4,267 $0.00
Jain Abhinav
Common Stock
2025-10-23 Grant 4,267 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 46 22,071,366
2025-12-31 39 22,199,542
2025-09-30 37 18,056,195
2025-06-30 32 5,282,659
2025-03-31 35 5,550,342
2024-12-31 37 4,138,316
2024-09-30 30 4,254,091
2024-06-30 32 6,418,891
2024-03-31 33 4,521,164
2023-12-31 34 6,852,584
2023-09-30 32 4,061,461
2023-06-30 28 1,073,700
Form 13F Holdings
Firm Period DFND Voting Shares
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 0 12,500
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com